ADOMALE ELBA: Open Payments
NPI 1871142307 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 38 payments from 9 companies in 2025. Trend: 2023 $18 · 2024 $61 · 2025 $613
Food & beverage: $613
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 20 | $268 |
| Janssen Pharmaceuticals, Inc | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| HARMONY BIOSCIENCES LLC | 2 | $44 |
| Lundbeck LLC | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Janssen Scientific Affairs, LLC | 1 | $14 |
Products named: FANAPT, INVEGA SUSTENNA, HETLIOZ, REXULTI, COBENFY, WAKIX, ABILIFY ASIMTUFII, CAPLYTA.
Industry payments across VA — which companies pay providers there.
